Global Space Medicine: Medical Challenges for Astronauts Travelling Beyond Low Earth Orbit

 

Space Medicine

Health Hazards of Space Travel

One of the greatest medical challenges of space travel is adapting to the microgravity environment of space. In microgravity, astronauts experience physiological changes as the body readjusts to being weightless. Bones and muscles deteriorate more quickly without the resistance of gravity. Prolonged periods of microgravity can lead to loss of bone mineral density and muscle atrophy. On average, astronauts lose 1-2% of bone mass per month in space. The effects are more pronounced in weight-bearing bones like the hips and spine. Muscle mass is also reduced by 20% on average after six months in space.

Another issue is the increased radiation exposure outside of Earth's protective atmosphere and magnetic field. Galactic cosmic radiation and solar particle events pose a significant cancer risk over multiple deep space missions or lengthy periods on another planetary surface like Mars. The human body has evolved to withstand low levels of radiation on Earth but not the elevated doses encountered outside low Earth orbit. Developing effective shielding and Space Medicine monitoring/countermeasures will be essential for long duration missions to the Moon and Mars.

One less obvious medical challenge is the immune system weakening in microgravity. Studies show astronauts display impaired immune function during flight, leaving them more susceptible to infection and slower to recover. The mechanisms are not fully understood but microgravity-induced stress, radiation exposure, interrupted sleep cycles, and confined living/working conditions onboard spacecraft all play a role. Counteracting immune system degradation will be an important area of ongoing research.

Physiological Impact of Extended Missions

Extended missions, lasting months or years, will take longer-term health effects of space travel to new frontiers. Scientists cannot be certain yet how the body will respond to prolonged periods away from Earth's gravity well, sustained higher radiation levels, and the additional stressors inherent in deep space exploration. Some predicted risks over multi-year missions include:

- Increased risk of renal stone formation due to changes in calcium regulation and fluid intake/output in microgravity. Stones could block kidney function and require surgery in deep space.

- Intracranial pressure changes and potential vision impairment issues from prolonged exposure to microgravity's effects on cranial fluid distribution and ocular structure/function.

- Elevated risks of cardiovascular deconditioning like atherosclerosis, blood clots, and arrhythmias over time due to aerobic fitness loss and other vasculopathic impacts of microgravity.

- Exacerbated muscle and bone deterioration if countermeasures are insufficient, leading to permanent injury/disability for some crew members after long missions.

- Higher cancer risks from cumulative exposure to deep space medicine over decades, especially concerning solid organ cancers like breast, colon, and pancreas with longer latent periods.

- As yet unknown interactions between prolonged microgravity adaptation, elevated radiation doses, high stress/workload environment, distance from definitive medical care facilities, and the challenge of maintaining crew health and performance far away from Earth.

Medical Countermeasures and Technology Needs

To address the health hazards of extended space exploration, significant medical countermeasure development is underway. Exercise protocols using advanced resistance equipment aim to mitigate muscle and bone loss. Improved food systems focus on delivering balanced nutrition tailored to individual crew needs. Pharmacological interventions study new drugs that could bolster bone mineral density and enhance vascular function in microgravity. Radiation shielding designs coupled with dosimeters allow for absorbed dose monitoring and emergency shelter deployment during solar particle events.

Telemedicine will play a key role, with remote guidance from specialists on Earth and rapid transmission of imaging and other diagnostic data. Onboard medical equipment like surgery-capable ultrasound, pharmaceutical printer labs producing responsive drugs, and diagnostic tools capable of analyzing biomarkers for important conditions becomes more essential. Radiation-hardened and miniaturized medical technologies help ensure a basic level of emergency and primary care capability far away from Earth. Stem cell therapies and gene editing advances also show promise to preemptively address expected health risks and injuries, whether administered terrestrially before launch or developed for in-space use.

The International Space Station provides a valuable testbed for validating and improving various countermeasures. But future exploration-class spacecraft and surface habitats in the Moon-Mars system demand even more autonomous and multifunctional medical solutions that consume minimal resources. Life support, pharmaceutical, nutritional, and diagnostic subsystems must seamlessly integrate to sustain astronaut health independent of continuous Earth-based control for months or years at a time. Advancing such self-sufficient global space medicine capabilities will prepare humanity to expand our presence throughout the solar system and beyond in a safe, sustainable manner.

Get More Insights On- Space Medicine